Patients with benign breast disease and breast cancer need more COVID-19 vaccines
Wu, H.; He, Z.; Gong, Y.; Mo, M.; Liu, G.-y.
Show abstract
Albeit the efficacy of COVID-19 vaccines in immunocompromised patients is undermined, it is still found beneficial. Patients with cancer have a much lower COVID-19 vaccination rate globally, and the vaccination coverage in breast cancer patients in China remains elusive. A total of 23029 patients with benign breast diseases and breast cancers were included in the study, and the vaccination rates of patients with benign breast tumors and other benign breast diseases, nonmetastatic and metastatic breast cancer were 44.0%, 54.7%, 19.2% and 9.6%, respectively. Breast cancer in situ patients had a similar vaccination rate with patients with benign breast tumors (45.9% vs 44.0%) while those with invasive breast cancer had much lower vaccination rates. The overall vaccination rate remains meager in breast cancer patients, and gap was found in patients with lower clinical stage. Hence vaccination should be further promoted among patients with benign breast diseases and breast cancer.
Matching journals
The top 13 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Breast and cervical cancer screening among women at reproductive age in Cambodia: Data analysis of Cambodia Demographic and Health Survey 2022 93%
- Knowledge towards breast cancer, and breast self-examination practices and its barriers among university female students in Bangladesh: Findings from a cross-sectional study 93%
- Glyoxalase 1: emerging biomarker and therapeutic target in cervical cancer progression 93%
Similar papers in this journal
- SARS-CoV-2 Seroprevalence and Risk Factors among Convalescents in Sichuan Province, China: a retrospective cohort study 91%
- Determinants of SARS-CoV-2 Vaccine Engagement in Algeria: A Population-based Study with Systematic Review of Studies from Arab Countries of the MENA Region 91%
- Effectiveness of COVID-19 Vaccines and Post-vaccination SARS-COV 2 Infection, Hospitalization, and Mortality: a Systematic Review and Meta-analysis of Observational Studies 91%
Similar papers in this journal
- Palliative care in the treatment of women with breast cancer: a scoping review protocol 93%
- p16 Expression and its correlation with the clinical pathological characteristics of cervical cancer patients: a systematic review and meta-Analysis 93%
- Adenovirus and RNA-based COVID-19 vaccines: perceptions and acceptance among healthcare workers 91%
Similar papers in this journal
- The NILS study protocol - a retrospective validation study of a preoperative decision-making tool for non-invasive lymph node staging in women with primary breast cancer [ISRCTN14341750] 91%
- Identification of prognostic biomarkers for suppressing tumorigenesis and metastasis of Hepatocellular carcinoma through transcriptome analysis 89%
- A Machine Learning Ensemble Based on Radiomics to Predict BI-RADS Category and Reduce the Biopsy Rate of Ultrasound-Detected Suspicious Breast Masses 89%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.